January 30, 2019
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment
Read More
January 30, 2019
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
Read More
January 30, 2019
Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Read More
January 30, 2019
Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Read More
January 30, 2019
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
Read More
January 30, 2019
Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
Read More
January 30, 2019
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial
Read More
January 30, 2019
Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection
Read More
January 30, 2019
Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
Read More
X